Journal of Clinical Medicine Article TRPV2 Calcium Channel Gene Expression and Outcomes in Gastric Cancer Patients: A Clinically Relevant Association Pietro Zoppoli 1 , Giovanni Calice 1 , Simona Laurino 1 , Vitalba Ruggieri 1, Francesco La Rocca 1 , Giuseppe La Torre 1, Mario Ciuffi 1, Elena Amendola 2, Ferdinando De Vita 3, Angelica Petrillo 3 , Giuliana Napolitano 2 , Geppino Falco 2,4,* and Sabino Russi 1,* 1 Laboratory of Preclinical and Translational Research, IRCCS—Referral Cancer Center of Basilicata (CROB), 85028 Rionero in Vulture (PZ), Italy;
[email protected] (P.Z.);
[email protected] (G.C.);
[email protected] (S.L.);
[email protected] (V.R.);
[email protected] (F.L.R.);
[email protected] (G.L.T.); mario.ciuffi@crob.it (M.C.) 2 Department of Biology, University of Naples Federico II, 80138 Naples, Italy;
[email protected] (E.A.);
[email protected] (G.N.) 3 Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania “Luigi Vanvitelli”, 80138 Naples, Italy;
[email protected] (F.D.V.);
[email protected] (A.P.) 4 Biogem, Istituto di Biologia e Genetica Molecolare, Via Camporeale, 83031 Ariano Irpino (AV), Italy * Correspondence:
[email protected] (G.F.);
[email protected] (S.R.); Tel.: +39-081-679092 (G.F.); +39-0972-726239 (S.R.) Received: 16 April 2019; Accepted: 8 May 2019; Published: 11 May 2019 Abstract: Gastric cancer (GC) is characterized by poor efficacy and the modest clinical impact of current therapies. Apoptosis evasion represents a causative factor for treatment failure in GC as in other cancers.